Costs of illness and care in Parkinson's Disease

• Autor(a) principal: von Campenhausen, Sonja
• Data de Publicação: 2011
• Outros Autores: Winter, Yaroslav, Rodrigues e Silva, Antonio, Sampaio, Christina, Ruzicka, Evzen, Barone, Paolo, Poewe, Werner, Guekht, Alla, Mateus, Céu, Pfeiffer, Karl P., Berger, Karin, Skoupa, Jana, Bötzel, Kai, Geiger-Gritsch, Sabine, Siebert, Uwe, Balzer-Geldsetzer, Monika, Oertel, Wolfgang H., Dodel, Richard, Reese, Jens P.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://doi.org/10.1016/j.euroneuro.2010.08.002
• topic: Care; Cost; Cost-of-illness; Economic burden; Europe; Parkinson's Disease; Pharmacology; Neurology; Clinical Neurology; Psychiatry and Mental health; Biological Psychiatry; Pharmacology (medical); SDG 3 - Good Health and Well-being

We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.